AllPennyStocks.com CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing

Compass has said a rolling FDA application is already underway for its COMP360, with the package due to be completed in the fourth quarter of 2026 and a possible U.S. launch in the first half of 2027.

Other Penny Stock Movers

Digestive Health Expansion Sends This Microcap Soaring
Utah Copper Explorer Jumps 19% on Surface Assays
Indonesian Gold Developer Jumps 27% as Ministry Moves File to Final Approval
Most Popular
{{ index + 1 }}
AllPennyStocks.com Favorites


Back to Top